Eli Lilly, the Indianapolis-based pharmaceutical giant, filed a lawsuit Sept. 19 in the Southern District Court of Georgia accusing a Georgia weight-loss clinic of manufacturing and selling drugs disguised as Lilly’s blockbuster diabetes drug Mounjaro. The lawsuit, part of a series of cases supported by King & Spalding, accuses Georgia Weight Loss & Aesthetics LLC of selling unapproved drugs that allegedly contain tirzepatide, the active pharmaceutical ingredient in Mounjaro. Two other similar lawsuits were filed the same day in Florida Middle District Court against two pharmacy companies. According to the Georgia lawsuit, Lilly is the sole supplier of FDA-approved tirzepatide drugs in the United States. No lawyers have appeared for the defendant yet. The case is 5:23-cv-00087, Eli Lilly and Company v. Georgia Weight Loss & Aesthetics, LLC.
This lawsuit was discovered by Law.com Radar, a source for fast legal news and litigation tailored to your practice. Law.com Radar provides daily updates on just-filed federal cases like this one. Click here to get started and be the first to hear about new suits in your region, practice area or customer sector.
Read the complaint here: